Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception
Public ClinicalTrials.gov record NCT01140217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether NEA TDS is effective in the prevention of pregnancy. The safety of this product will also be evaluated.
Study identification
- NCT ID
- NCT01140217
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,659 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Sep 19, 2013
2010 – 2012
United States locations
- U.S. sites
- 53
- U.S. states
- 29
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site | Birmingham | Alabama | — | — |
| Watson Investigational Site | Mobile | Alabama | — | — |
| Watson Investigational Site | Montgomery | Alabama | — | — |
| Watson Investigational Site | Chandler | Arizona | — | — |
| Watson Investigational Site | Little Rock | Arkansas | — | — |
| Watson Investigational Site | Garden Grove | California | — | — |
| Watson Investigational Site | La Mesa | California | — | — |
| Watson Investigational Site | San Diego | California | — | — |
| Watson Investigational Site | Denver | Colorado | — | — |
| Watson Investigational Site | Newark | Delaware | — | — |
| Watson Investigational Site | Washington D.C. | District of Columbia | — | — |
| Watson Investigational Site | Aventura | Florida | — | — |
| Watson Investigational Site | Daytona Beach | Florida | — | — |
| Watson Investigational Site | Jacksonville | Florida | — | — |
| Watson Investigational Site | Lake Worth | Florida | — | — |
| Watson Investigational Site | Miami | Florida | — | — |
| Watson Investigational Site | North Miami | Florida | — | — |
| Watson Investigational Site | Pinellas Park | Florida | — | — |
| Watson Investigational Site | Sarasota | Florida | — | — |
| Watson Investigational Site | Atlanta | Georgia | — | — |
| Watson Investigational Site | Decatur | Georgia | — | — |
| Watson Investigational Site | Sandy Springs | Georgia | — | — |
| Watson Investigational Site | Savannah | Georgia | — | — |
| Watson Investigational Site | Chicago | Illinois | — | — |
| Watson Investigational Site | Overland Park | Kansas | — | — |
| Watson Investigational Site | Marrero | Louisiana | — | — |
| Watson Investigational Site | New Orleans | Louisiana | — | — |
| Watson Investigational Site | Haverhill | Massachusetts | — | — |
| Watson Investigational Site | Ann Arbor | Michigan | — | — |
| Watson Investigational Site | Kalamazoo | Michigan | — | — |
| Watson Investigational Site | Edina | Minnesota | — | — |
| Watson Investigational Site | Las Vegas | Nevada | — | — |
| Watson Investigational Site | Lawrenceville | New Jersey | — | — |
| Watson Investigational Site | Albuquerque | New Mexico | — | — |
| Watson Investigational Site | New York | New York | — | — |
| Watson Investigational Site | Chapel Hill | North Carolina | — | — |
| Watson Investigational Site | New Bern | North Carolina | — | — |
| Watson Investigational Site | Raleigh | North Carolina | — | — |
| Watson Investigational Site | Cleveland | Ohio | — | — |
| Watson Investigational Site | Columbus | Ohio | — | — |
| Watson Investigational Site | Medford | Oregon | — | — |
| Watson Investigational Site | Philadelphia | Pennsylvania | — | — |
| Watson Investigational Site | Columbia | South Carolina | — | — |
| Watson Investigational Site | Greer | South Carolina | — | — |
| Watson Investigational Site | Hilton Head Island | South Carolina | — | — |
| Watson Investigational Site | Nashville | Tennessee | — | — |
| Watson Investigational Site | Austin | Texas | — | — |
| Watson Investigational Site | Dallas | Texas | — | — |
| Watson Investigational Site | Houston | Texas | — | — |
| Watson Investigational Site | San Antonio | Texas | — | — |
| Watson Investigational Site | Salt Lake City | Utah | — | — |
| Watson Investigational Site | Norfolk | Virginia | — | — |
| Watson Investigational Site | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01140217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01140217 live on ClinicalTrials.gov.